Cover Image
市場調查報告書

糖尿病神經病變性腳潰瘍:全球臨床實驗趨勢

Diabetic Neuropathic Foot Ulcers Global Clinical Trials Review, H1, 2016

出版商 GlobalData 商品編碼 301438
出版日期 內容資訊 英文 43 Pages
訂單完成後即時交付
價格
Back to Top
糖尿病神經病變性腳潰瘍:全球臨床實驗趨勢 Diabetic Neuropathic Foot Ulcers Global Clinical Trials Review, H1, 2016
出版日期: 2016年05月31日 內容資訊: 英文 43 Pages
簡介

本報告提供全球糖尿病神經病變性腳潰瘍治療藥臨床實驗趨勢的相關調查,提供您已開發國家及新興國家市場上臨床實驗數量,各階段及各進展狀況臨床實驗數量,參與治療藥臨床實驗之主要企業,有潛力的藥劑等資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:代謝異常治療藥臨床實驗上糖尿病神經病變性腳潰瘍的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:代謝異常治療藥臨床實驗上糖尿病神經病變性腳潰瘍的比例

E7各國的各階段臨床實驗數量

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

糖尿病神經病變性腳潰瘍治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介概要

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3440CTIDB

GlobalData's clinical trial report, "Diabetic Neuropathic Foot Ulcers Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Neuropathic Foot Ulcers clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Neuropathic Foot Ulcers. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • Clinical Trials by Region 5
  • Clinical Trials and Average Enrollment by Country 6
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Clinical Trials by G7 Countries: Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials 13
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials 27
  • Prominent Drugs 28
  • Clinical Trial Profile Snapshots 29

Appendix 40

  • Abbreviations 40
  • Definitions 40
  • Research Methodology 41
  • Secondary Research 41
  • About GlobalData 42
  • Contact Us 42
  • Disclaimer 42
  • Source 43

List of Tables

  • Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Region, 2016* 5
  • Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 9
  • Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
  • Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
  • Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
  • Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016* 14
  • Diabetic Neuropathic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Diabetic Neuropathic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016* 18
  • Diabetic Neuropathic Foot Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
  • Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Phase, 2016* 20
  • Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
  • Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Diabetic Neuropathic Foot Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
  • Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
  • Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List of Figures

  • Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
  • Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
  • Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
  • Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
  • Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
  • Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials, G7 Countries (%), 2016* 13
  • Diabetic Neuropathic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Diabetic Neuropathic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials, E7 Countries (%), 2016* 17
  • Diabetic Neuropathic Foot Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
  • Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
  • Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
  • Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Diabetic Neuropathic Foot Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
  • Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
  • Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
  • GlobalData Methodology 41
Back to Top